NORCROSS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP) developer of the LuViva® Advanced Cervical Scan, a non-invasive device used to detect cervical disease that leads to cancer, today announced that it will be a featured presenter at the Rodman & Renshaw 16th Annual Global Investment Conference on Wednesday, September 10, 2014 at the New York Palace Hotel in New York City.
The Company’s presentation by Chief Executive Officer Gene Cartwright is scheduled to begin at 9:10 a.m. EDT and will be available via a live webcast. To access the webcast, go to the Investor page of the Company’s web site http://www.guidedinc.com/Investors.htm. The webcast will also be available at http://wsw.com/webcast/rrshq24/gthp. A replay will be available for 90 days.
Hey, check out all the research scientist jobs. Post your resume today!
